Menú

GRenSSAP
GRenSSAP

Group leader
avatar_investigadors.jpg
Anna Berenguera Ossó
avatar_grups_recerca.png

Projectes

Group projects

A post-authorisation safety study of ABRYSVO in immunocompromised, or renally or hepatically impaired adults aged 60 years and older in a real world setting in Europe and UK

  • Principal investigators: Felipe Villalobos Martínez
  • Code: 4RNC-0-00018-25
  • Start year: 2025

Estudio de utilización de medicamentos para el tratamiento de la insuficiencia cardíaca (IDIAP-IC-2025)

  • Principal investigators: Maria Giner Soriano
  • Code: 4RNC-0-00095-25
  • Start year: 2025

Estudi d’utilització de medicaments per al tractament de la malaltia pulmonar obstructiva crònica a Catalunya

  • Principal investigators: Maria Giner Soriano
  • Code: 4RNC-0-00124-25
  • Start year: 2025

ORION (Ozanimod Real-World Safety – A Post-Authorisation Multinational Long-Term Non-Interventional Study)

  • Principal investigators: Maria Giner Soriano
  • Code: 4RNC-0-00192-25
  • Start year: 2025
  • Funders: Evidera, Inc.

Experiencias y conocimientos de pacientes y profesionales sanitarios sobre la migraña (Estudio PREMI): Estudio Cualitativo

  • Principal investigators: Maria Giner Soriano
  • Code: 4RNC-0-00208-25
  • Start year: 2025